-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Nitazoxanide-[d4]
Category | Influenza Virus |
CAS | 1246819-17-9 |
Description | The isotope labelled Nitazoxanide which could used as an anthelmintic agent. |
Product Information
Synonyms | 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide-d4; Alinia-d4; BRN 1225475-d4; Cryptaz-d4; DRG 0242-d4; N-(5-Nitro-2-thiazolyl)salicylamide-d4 Acetate Ester; Nitacure-d4; Nitarid-d4; Nitazoxanida-d4; Nixide-d4; Nixoran-d4; Nizonide-d4 |
IUPAC Name | [2,3,4,5-tetradeuterio-6-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate |
Molecular Weight | 311.31 |
Molecular Formula | C12H5D4N3O5S |
Canonical SMILES | CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-] |
InChI | InChI=1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)/i2D,3D,4D,5D |
InChIKey | YQNQNVDNTFHQSW-QFFDRWTDSA-N |
Melting Point | >122°C (dec.) |
Purity | >98% |
Solubility | Soluble in DMSO (Slightly), Methanol (Slightly, Heated) |
Appearance | Brown to Dark Brown Solid |
Application | The isotope labelled Nitazoxanide. |
Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
Storage | Store at -20°C |
Complexity | 428 |
Exact Mass | 311.05139855 |
PSA | 142.35000 |
Target | Influenza Virus |
XLogP3-AA | 2 |